DEODATO GALLERY SPA (ART.MI) Fundamental Analysis & Valuation

BIT:ART • IT0005528937

Current stock price

0.242 EUR
-0.01 (-4.72%)
Last:

This ART.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. ART.MI Profitability Analysis

1.1 Basic Checks

  • In the past year ART has reported negative net income.
  • ART had a positive operating cash flow in the past year.
ART.MI Yearly Net Income VS EBIT VS OCF VS FCFART.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 1M -1M -2M

1.2 Ratios

  • ART has a worse Return On Assets (1.05%) than 62.30% of its industry peers.
  • Looking at the Return On Equity, with a value of 2.35%, ART is in line with its industry, outperforming 50.82% of the companies in the same industry.
  • ART's Return On Invested Capital of 3.16% is on the low side compared to the rest of the industry. ART is outperformed by 63.93% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ART is above the industry average of 11.43%.
  • The 3 year average ROIC (13.79%) for ART is well above the current ROIC(3.16%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 1.05%
ROE 2.35%
ROIC 3.16%
ROA(3y)6.18%
ROA(5y)N/A
ROE(3y)16.81%
ROE(5y)N/A
ROIC(3y)13.79%
ROIC(5y)N/A
ART.MI Yearly ROA, ROE, ROICART.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 20 40 60

1.3 Margins

  • Looking at the Profit Margin, with a value of 1.24%, ART is doing worse than 63.93% of the companies in the same industry.
  • In the last couple of years the Profit Margin of ART has declined.
  • ART has a worse Operating Margin (2.74%) than 67.21% of its industry peers.
  • In the last couple of years the Operating Margin of ART has declined.
  • ART has a Gross Margin (25.49%) which is comparable to the rest of the industry.
  • ART's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.74%
PM (TTM) 1.24%
GM 25.49%
OM growth 3Y-50.63%
OM growth 5YN/A
PM growth 3Y-57.05%
PM growth 5YN/A
GM growth 3Y-9.55%
GM growth 5YN/A
ART.MI Yearly Profit, Operating, Gross MarginsART.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. ART.MI Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ART is creating value.
  • The number of shares outstanding for ART remains at a similar level compared to 1 year ago.
  • The debt/assets ratio for ART is higher compared to a year ago.
ART.MI Yearly Shares OutstandingART.MI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M
ART.MI Yearly Total Debt VS Total AssetsART.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

  • ART has an Altman-Z score of 2.50. This is not the best score and indicates that ART is in the grey zone with still only limited risk for bankruptcy at the moment.
  • ART's Altman-Z score of 2.50 is fine compared to the rest of the industry. ART outperforms 67.21% of its industry peers.
  • The Debt to FCF ratio of ART is 12.11, which is on the high side as it means it would take ART, 12.11 years of fcf income to pay off all of its debts.
  • ART has a worse Debt to FCF ratio (12.11) than 62.30% of its industry peers.
  • ART has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
  • With an excellent Debt to Equity ratio value of 0.12, ART belongs to the best of the industry, outperforming 83.61% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 12.11
Altman-Z 2.5
ROIC/WACC0.44
WACC7.26%
ART.MI Yearly LT Debt VS Equity VS FCFART.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M -2M 4M

2.3 Liquidity

  • A Current Ratio of 1.96 indicates that ART should not have too much problems paying its short term obligations.
  • ART has a better Current ratio (1.96) than 98.36% of its industry peers.
  • A Quick Ratio of 1.06 indicates that ART should not have too much problems paying its short term obligations.
  • With a decent Quick ratio value of 1.06, ART is doing good in the industry, outperforming 70.49% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.96
Quick Ratio 1.06
ART.MI Yearly Current Assets VS Current LiabilitesART.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. ART.MI Growth Analysis

3.1 Past

  • ART shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 400.00%, which is quite impressive.
  • Measured over the past years, ART shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -50.75% on average per year.
  • Looking at the last year, ART shows a very negative growth in Revenue. The Revenue has decreased by -14.67% in the last year.
  • Measured over the past years, ART shows a quite strong growth in Revenue. The Revenue has been growing by 14.70% on average per year.
EPS 1Y (TTM)400%
EPS 3Y-50.75%
EPS 5YN/A
EPS Q2Q%81.67%
Revenue 1Y (TTM)-14.67%
Revenue growth 3Y14.7%
Revenue growth 5YN/A
Sales Q2Q%-23.07%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ART.MI Yearly Revenue VS EstimatesART.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

Find the best growth stocksShow best growing peers

0

4. ART.MI Valuation Analysis

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
ART.MI Price Earnings VS Forward Price EarningsART.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • ART's Enterprise Value to EBITDA is on the same level as the industry average.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ART indicates a slightly more expensive valuation: ART is more expensive than 67.21% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 44.55
EV/EBITDA 12.41
ART.MI Per share dataART.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.05 0.1 0.15 0.2 0.25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ART.MI Dividend Analysis

5.1 Amount

  • ART does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ART.MI Fundamentals: All Metrics, Ratios and Statistics

DEODATO GALLERY SPA

BIT:ART (3/25/2026, 7:00:00 PM)

0.242

-0.01 (-4.72%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.11%
Inst Owner ChangeN/A
Ins Owners83.3%
Ins Owner ChangeN/A
Market Cap7.58M
Revenue(TTM)8.87M
Net Income(TTM)109.60K
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.85
P/FCF 44.55
P/OCF 21.51
P/B 1.62
P/tB 2.05
EV/EBITDA 12.41
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.01
FCFY2.24%
OCF(TTM)0.01
OCFY4.65%
SpS0.28
BVpS0.15
TBVpS0.12
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 1.05%
ROE 2.35%
ROCE 4.21%
ROIC 3.16%
ROICexc 4.55%
ROICexgc 5.99%
OM 2.74%
PM (TTM) 1.24%
GM 25.49%
FCFM 1.92%
ROA(3y)6.18%
ROA(5y)N/A
ROE(3y)16.81%
ROE(5y)N/A
ROIC(3y)13.79%
ROIC(5y)N/A
ROICexc(3y)18.08%
ROICexc(5y)N/A
ROICexgc(3y)22.97%
ROICexgc(5y)N/A
ROCE(3y)18.39%
ROCE(5y)N/A
ROICexgc growth 3Y-56.79%
ROICexgc growth 5YN/A
ROICexc growth 3Y-59.09%
ROICexc growth 5YN/A
OM growth 3Y-50.63%
OM growth 5YN/A
PM growth 3Y-57.05%
PM growth 5YN/A
GM growth 3Y-9.55%
GM growth 5YN/A
F-Score7
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 12.11
Debt/EBITDA 0.95
Cap/Depr 50.07%
Cap/Sales 2.05%
Interest Coverage 250
Cash Conversion 58.02%
Profit Quality 155.29%
Current Ratio 1.96
Quick Ratio 1.06
Altman-Z 2.5
F-Score7
WACC7.26%
ROIC/WACC0.44
Cap/Depr(3y)231.4%
Cap/Depr(5y)N/A
Cap/Sales(3y)5.97%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)400%
EPS 3Y-50.75%
EPS 5YN/A
EPS Q2Q%81.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-14.67%
Revenue growth 3Y14.7%
Revenue growth 5YN/A
Sales Q2Q%-23.07%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y76.45%
EBIT growth 3Y-43.38%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y107.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y126.72%
OCF growth 3YN/A
OCF growth 5YN/A

DEODATO GALLERY SPA / ART.MI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of DEODATO GALLERY SPA (ART.MI) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ART.MI.


What is the valuation status for ART stock?

ChartMill assigns a valuation rating of 0 / 10 to DEODATO GALLERY SPA (ART.MI). This can be considered as Overvalued.


How profitable is DEODATO GALLERY SPA (ART.MI) stock?

DEODATO GALLERY SPA (ART.MI) has a profitability rating of 2 / 10.


Can you provide the financial health for ART stock?

The financial health rating of DEODATO GALLERY SPA (ART.MI) is 5 / 10.